{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:47:58Z","timestamp":1740134878341,"version":"3.37.3"},"reference-count":8,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3,7]]},"DOI":"10.1182\/blood.2023023037","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T16:30:44Z","timestamp":1709829044000},"page":"840-841","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Waking up exhausted BCMA-specific T cells in myeloma"],"prefix":"10.1182","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2945-9416","authenticated-orcid":false,"given":"Antonio","family":"Sacco","sequence":"first","affiliation":[{"name":"Azienda Socio Sanitaria Territoriale Spedali Civili di Brescia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1872-5128","authenticated-orcid":false,"given":"Aldo M.","family":"Roccaro","sequence":"additional","affiliation":[{"name":"Azienda Socio Sanitaria Territoriale Spedali Civili di Brescia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"10","key":"2024030716302393000_bib1","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1182\/blood.2023020528","article-title":"Differentiation of BCMA-specific induced pluripotent stem cells into rejuvenated CD8\u03b1\u03b2+ T cells targeting multiple myeloma","volume":"143","author":"Bae","year":"2024","journal-title":"Blood"},{"issue":"4","key":"2024030716302393000_bib2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa2303379","article-title":"Cilta-cel or standard care in lenalidomide-refractory multiple myeloma","volume":"389","author":"San-Miguel","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"2024030716302393000_bib3","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1056\/NEJMoa1817226","article-title":"Anti-BCMA CAR T-cell therapy bb2121 in relapsed or refractory multiple myeloma","volume":"380","author":"Raje","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"2024030716302393000_bib4","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.3324\/haematol.2022.280482","article-title":"Adjusted comparison of outcomes between patients from CARTITUDE-1 versus multiple myeloma patients with prior exposure to proteasome inhibitors, immunomodulatory drugs and anti-CD38 antibody from the prospective, multinational LocoMMotion study of real-world clinical practice","volume":"108","author":"Mateos","year":"2023","journal-title":"Haematologica"},{"issue":"13","key":"2024030716302393000_bib5","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1056\/NEJMoa2209900","article-title":"GPRC5D-targeted CAR T cells for myeloma","volume":"387","author":"Mailankody","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"14","key":"2024030716302393000_bib6","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJMoa2210859","article-title":"GD2-CART01 for relapsed or refractory high-risk neuroblastoma","volume":"388","author":"Del Bufalo","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"14","key":"2024030716302393000_bib7","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1056\/NEJMe2300317","article-title":"CAR T cells for neuroblastoma","volume":"388","author":"Yeku","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"2024030716302393000_bib8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJMcibr1811991","article-title":"Steering CAR T cells into solid tumors","volume":"380","author":"Brown","year":"2019","journal-title":"N\u00a0Engl J Med"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/143\/10\/840\/2217066\/blood_bld-2023-023037-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/143\/10\/840\/2217066\/blood_bld-2023-023037-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T16:30:56Z","timestamp":1709829056000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/143\/10\/840\/515102\/Waking-up-exhausted-BCMA-specific-T-cells-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,7]]},"references-count":8,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,3,7]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2023023037","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"type":"print","value":"0006-4971"},{"type":"electronic","value":"1528-0020"}],"subject":[],"published":{"date-parts":[[2024,3,7]]}}}